Stock Information
Replimune Group Inc (REPL)
Ticker Symbol: REPL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $694.44 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -3.16
Revenue (TTM): $0.00 M
Dividend Yield: N/A
ROE: -159.32%
Latest News
-
Replimune Announces TUDRIQEV⢠Now Available in the U.S. for Advanced Melanoma
Thu, Oct 1, 2026 8:01 PM
-
Replimune Group Announces Commercial Availability Of TUDRIQEV In U.S. To Treat Unresectable Advanced Cutaneous Melanoma
Thu, Oct 1, 2026 4:02 PM
Key Financials
Financial data not available